Health-care providers' compliance with childhood acute lymphoblastic leukemia protocol in Indonesia

Pediatric Blood and Cancer

Volumn 51, Issue 6, 2008, Pages 732-736

  Sitaresmi, Mei Neni ^a   Mostert, Saskia ^b   Gundy, Chad M ^c   Sutaryo, ^a   Veerman, Anjo J P ^b  

^a GADJAH MADA UNIVERSITY   (Indonesia)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Childhood acute lymphoblastic leukemia; Compliance; Developing country; Health care providers; Protocol

Indexed keywords

ANTILEUKEMIC AGENT;

ACCURACY; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; ATTITUDE TO HEALTH; CANCER CHEMOTHERAPY; CANCER RISK; CHILD; CHILDHOOD CANCER; DRUG ADMINISTRATION; DRUG RESPONSE; HEALTH CARE PERSONNEL; HIGH RISK BEHAVIOR; HUMAN; INDONESIA; INFANT; KNOWLEDGE MANAGEMENT; LEUKOCYTE COUNT; LYMPHOBLAST; MAJOR CLINICAL STUDY; MEDICAL RECORD; PATIENT CODING; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; GUIDELINE ADHERENCE; HEALTH PERSONNEL; HUMANS; INDONESIA; INFANT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 56749178961     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21698     Document Type: Article

References (24)

1. Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004;291:2471-2475.
2. Magrath I, Shanta V, Advani S, et al. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period. Eur J Cancer 2005;41:1570-1583.
3. Metzger ML, Howard SC, Fu LC, et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet 2003;362:706-708.
4. Powell JE, Mendez E, Parkes SE, et al. Factors affecting survival in White and Asian children with acute lymphoblastic leukaemia. Br J Cancer 2000;82:1568-1570.
5. Ribeiro RC, Pui CH. Saving the children - Improving childhood cancer treatment in developing countries. N Engl J Med 2005;352:2158-2160.
6. Pui CH, Campana D, Evans WE. Childhood acute lymphoblastic leukaemia - Current status and future perspectives. Lancet Oncol 2001;2:597-607.
7. Davies HA, Lilleyman JS. Compliance with oral chemotherapy in childhood lymphoblastic leukaemia. Cancer Treat Rev 1995;21:93-103.
8. Lancaster D, Lennard L, Lilleyman JS. Profile of non-compliance in lymphoblastic leukaemia. Arch Dis Child 1997;76:365-366.
9. Oliveira BM, Viana MB, Zani CL, et al. Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemia. Arch Dis Child 2004;89:785-788.
10. Oliveira BM, Viana MB, Arruda LM, et al. Evaluation of compliance through specific interviews: A prospective study of 73 children with acute lymphoblastic leukemia. J Pediatr 2005;81:245-250.
11. Partridge AH, Avorn J, Wang PS, et al. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 2002;94:652-661.
12. Tamaroff MH, Festa RS, Adesman AR, et al. Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates. J Pediatr 1992;120:812-817.
13. Tebbi CK. Treatment compliance in childhood and adolescence. Cancer 1993;71:3441-3449.
14. Sutaryo, Sumadiono, Suhadi, et al. The pilot protocol of wijaya kusuma acute lymphoblastic leukemia of childhood 1999. Indonesian multicentre study group, Yogyakarta, Indonesia: Gadjah Mada University Press; 1999.
15. Sutaryo, Sumadiono, Suhadi, et al. The protocol of wijaya kusuma acute lymphoblastic leukemia of childhood 2000. Indonesian multicentre study group, Yogyakarta, Indonesia: Gadjah Mada University Press; 2000.
16. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-497.
17. Donadieu J, Hill C. Early response to chemotherapy as a prognostic factor in childhood acute lymphoblastic leukaemia: A methodological review. Br J Haematol 2001;115:34-45.
18. Gaynon PS, Desai AA, Bostrom BC, et al. Early response to therapy and outcome in childhood acute lymphoblastic leukemia: A review. Cancer 1997;80:1717-1726.
19. Mostert S, Sitaresmi MN, Gundy CM, et al. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics 2006;118:e1600-e1606.
20. Bury J, Hurt C, Roy A, et al. LISA: Aweb-based decision-support system for trial management of childhood acute lymphoblastic leukaemia. Br J Haematol 2005;129:746-754.
21. Donovan JL, Blake DR. Patient non-compliance: Deviance or reasoned decision-making? Soc Sci Med 1992;34:507-513.
22. Reynolds NR, Testa MA, Marc LG, et al. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: A multicenter, cross-sectional study. AIDS Behav 2004;8:141-150.
23. Winnick S, Lucas DO, Hartman AL, et al. How do you improve compliance? Pediatrics 2005;115:e718-e724.
24. Miller LG, Liu H, Hays RD, et al. How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med 2002;17:1-11.